Sanofi Workers Strike Over Sale of Doliprane Unit to American Firm

Employees protest the potential sale of Sanofi's Opella division to a U.S. investment fund, citing fears of job losses and threats to France's pharmaceutical sovereignty.

• Sanofi employees at the Compiègne site have initiated an indefinite strike against the sale of 50% of its Opella division to American fund CD&R.
• The workers express concerns over potential job losses and the relocation of production to the U.S., threatening France's pharmaceutical independence.
• A French investment fund, PAI, has submitted a new, higher bid to acquire the Opella division, challenging the American offer.
• Government officials are attempting to reassure the public and employees by emphasizing commitments to maintain jobs and production in France.
• Sanofi's president has promised job security, but skepticism remains among workers and political figures who demand written guarantees.

35 Articles

L'Express Libération Le Nouvel Obs Le Parisien L'Express Marianne Sud Ouest l'Opinion Le Parisien Libération L'Humanité L'Express Le Figaro l'Opinion Libération Le Parisien Le Figaro Le Figaro Le Parisien Le Point Le Parisien Courrier International Le Point Le Monde Ouest-France Libération L'Humanité Le Parisien Le Figaro l'Opinion Marianne Libération Le Parisien L'Express Le Figaro